Reference health
Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation
43/43 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 43 checked references that resolve
resolves10.2165/00003495-200363150-00004
Long-Term Complications of Chemotherapy for Germ Cell Tumours
resolves10.1007/s11912-005-0007-z
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
resolves10.1016/j.ygyno.2007.01.039
A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study
resolves10.1023/A:1008328501128
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer
resolves10.3346/jkms.2007.22.S.S115
Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
resolves10.1007/s10863-006-9059-5
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer
resolves10.1634/theoncologist.2010-S3-03
Induction Chemotherapy for Head and Neck Cancer: Recent Data
resolves10.1200/JCO.2005.09.071
Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732
resolves10.1016/S0140-6736(00)02044-4
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer
resolves10.1186/1472-6904-8-7
Long-term platinum retention after treatment with cisplatin and oxaliplatin
resolves10.1016/0959-8049(92)90519-8
The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy
resolves10.1080/028418600750013447
Urinary Excretion of Platinum in Chemotherapy-treated Long-term Survivors of Testicular Cancer
resolves10.1200/JCO.1992.10.5.795
Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.
resolves10.1200/JCO.1999.17.1.409
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
resolves10.1016/S0378-5955(02)00771-2
Influence of pH on the ototoxicity of cisplatin: a round window application study
resolves10.3109/00206090109073130
Apoptosis in the OC-k3 Immortalized Cell Line Treated with Different Agents: Apoptosis en linea celular OC k3 inmortalizada, tratada con diferentes agentes
resolves10.1016/j.heares.2004.04.009
RNA expression induced by cisplatin in an organ of Corti-derived immortalized cell line
resolves10.1016/j.tox.2006.02.007
Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm
resolves10.1097/01.mlg.0000197630.85208.36
The Histone Deacetylase Inhibitor Sodium Butyrate Protects Against Cisplatin‐Induced Hearing Loss in Guinea Pigs
resolves10.1016/j.ctrv.2006.09.006
Molecular mechanisms of resistance and toxicity associated with platinating agents
resolves10.1002/j.1875-9114.1996.tb02913.x
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal
resolves10.1016/j.otohns.2007.05.068
The protective effect of intratympanic dexamethasone on cisplatin‐induced ototoxicity in guinea pigs
resolves10.1080/16513860802527930
In vitro protective effects of Ginkgo biloba against cisplatin toxicity in mouse cell line OCk3
resolves10.1002/cncr.21683
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma
resolves10.1097/01.cad.0000176507.78928.4d
Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
resolves10.1007/s12094-007-0008-5
Long term results of a phase II trial of Induction Chemotherapy with Uracil-Ftegafur (UFT), Vinorelbine and Cisplatin (UFTVP) followed by Radiotherapy concomitant with UFT and Carboplatin (RT/UFTJ) in Non-Resectable Locally Advanced (Stage IV-B) Squamous Cell Head and Neck Carcinoma and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia
resolves10.1593/neo.06661
Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract
resolves10.1016/j.radonc.2008.06.003
Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer
resolves10.1200/JCO.2006.06.9591
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
resolves10.1053/sonc.2002.30750
Current and future perspectives in advanced bladder cancer: Is there a new standard?
The 7 references without a DOI — listed, not checked
no DOI — not checkedCisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects
no DOI — not checkedClinical and pharmacological studies with cis-diamminedichloroplatinum (II)
no DOI — not checkedCisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents
no DOI — not checkedCisplatin-induced apoptosis in human promyelocytic leukemia cells
no DOI — not checkedCytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal
no DOI — not checkedRegione Emilia-Romagna certified (Internet)Reportistica predefinita REM anno2006(updated 2007 Oct 30). Available from: http://www.regione.emilia-romagna.it/sas/rem/report_predef/2006/REM05_2.htm
no DOI — not checkedNational Cancer InstituteGastrointestinal Complications PDQ®2012National Cancer InstituteBethesda, MD(Updated 07/18/2012). Available from: http://cancer.gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3892/or.2013.2279"><img src="https://citestamp.com/citestamped/10.3892/or.2013.2279/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3892/or.2013.2279)